NEPHROS INC (NEPH) Stock Price & Overview
NASDAQ:NEPH • US6406714005
The current stock price of NEPH is 3.8 USD. Today NEPH is down by -3.31%. In the past month the price decreased by -5.94%. In the past year, price increased by 133.14%.
NEPH Key Statistics
- Market Cap
- 40.394M
- P/E
- 29.23
- Fwd P/E
- 24.84
- EPS (TTM)
- 0.13
- Dividend Yield
- N/A
NEPH Stock Performance
NEPH Stock Chart
NEPH Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to NEPH. When comparing the yearly performance of all stocks, NEPH is one of the better performing stocks in the market, outperforming 93.03% of all stocks.
NEPH Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to NEPH. While NEPH has a great health rating, its profitability is only average at the moment.
NEPH Earnings
On March 12, 2026 NEPH reported an EPS of 0.01 and a revenue of 4.73M. The company missed EPS expectations (-1.96% surprise) and beat revenue expectations (4.19% surprise).
NEPH Forecast & Estimates
8 analysts have analysed NEPH and the average price target is 7.14 USD. This implies a price increase of 87.89% is expected in the next year compared to the current price of 3.8.
For the next year, analysts expect an EPS growth of 3233944820422206000% and a revenue growth 33.54% for NEPH
NEPH Groups
Sector & Classification
NEPH Financial Highlights
Over the last trailing twelve months NEPH reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 244.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.26% | ||
| ROA | 11.18% | ||
| ROE | 14.8% | ||
| Debt/Equity | 0 |
NEPH Ownership
NEPH Latest News, Press Relases and Analysis
NEPH Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| PH | PARKER HANNIFIN CORP | 25.78 | 118.707B | ||
| ITW | ILLINOIS TOOL WORKS | 23.36 | 78.252B | ||
| IR | INGERSOLL-RAND INC | 22.13 | 33.651B | ||
| OTIS | OTIS WORLDWIDE CORP | 18.68 | 32.886B | ||
| SYM | SYMBOTIC INC | 45.42 | 30.717B | ||
| XYL | XYLEM INC | 21.59 | 29.748B | ||
| DOV | DOVER CORP | 19.15 | 28.369B | ||
| SNA | SNAP-ON INC | 18.07 | 19.195B | ||
| RBC | RBC BEARINGS INC | 38.86 | 17.692B | ||
| FTV | FORTIVE CORP | 18.44 | 17.336B | ||
| ITT | ITT INC | 25.71 | 16.268B | ||
| NDSN | NORDSON CORP | 21.33 | 15.266B | ||
| LECO | LINCOLN ELECTRIC HOLDINGS | 23.6 | 14.618B |
Related stock screener links
View all stocks in the Industrial Machinery & Supplies & Components Industry | View all stocks in the Industrials Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NEPH
Company Profile
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 31 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Company Info
IPO: 2004-09-21
NEPHROS INC
380 Lackawanna Pl
South Orange NEW JERSEY 07079 US
CEO: Andrew Astor
Employees: 31
Phone: 12013435202
NEPHROS INC / NEPH FAQ
What does NEPH do?
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 31 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Can you provide the latest stock price for NEPHROS INC?
The current stock price of NEPH is 3.8 USD. The price decreased by -3.31% in the last trading session.
What is the dividend status of NEPHROS INC?
NEPH does not pay a dividend.
What is the ChartMill technical and fundamental rating of NEPH stock?
NEPH has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How is the market expecting NEPH stock to perform?
8 analysts have analysed NEPH and the average price target is 7.14 USD. This implies a price increase of 87.89% is expected in the next year compared to the current price of 3.8.
What sector and industry does NEPHROS INC belong to?
NEPHROS INC (NEPH) operates in the Industrials sector and the Machinery industry.
What is the employee count for NEPH stock?
NEPHROS INC (NEPH) currently has 31 employees.